Lyme Disease Practice and Research

Lyme Disease Practice & Research Site

LDPR'ss office is stategically located in Mt. Kisco, New York. The practice provides primary care, enabling LDPR to comfortably accommodate many types of clinical studies.

The staff of the LDPR consists of trained clinicians, researchers, and support staff dedicated to providing the best in patient-oriented clinical research.

Benefits of Lyme Disease Research

Lyme disease patients benefit directly from the the research done by Lyme disease research and practice (LDPR). Through LDPR, they gain access to clinical trials by the same doctors who are treating them, and they are often among the first to receive new, proven therapies for their disease. "We're leading the standard of care" says Dr. Daniel J. Cameron, a nationally renowned expert in the Lyme disease field who is director of the Lyme Disease Practice and Research.

Dr. Cameron takes leadership roles in an international Lyme disease society called ILADS. Dr. Cameron is the lead author of a recently peer reviewed published treatment guideline for Lyme disease. This treatment guideline used used evidence based medicine in Lyme disease patients. These guidelines have become a standard of care in the treatment of Lyme disease.

These guidelines were developed by 17 professionals around the country and was sponsered by the International Lyme and Associated Disease Society (ILADS), a nonprofit, international, multidisciplinary medical society, dedicated to the diagnosis and appropriate treatment of Lyme and its associated diseases. The guidelines were published in the 2004 edition of Expert Rev. Anti-infect. Ther. 2(1).

Why primary care research

This primary care setting is uniquely relevant to chronic Lyme disease epidemiology, given the availability of front line personnel treating Lyme disease, the ability to examine the entire cohort of Lyme disease patients, and the potential for conducting rapidly evolving or emergent research. Research in the primary care setting resolves methodologic problems, such as documenting the accuracy of a customary procedure in preparation for use in epidemiologic research (referral bias), or evaluating the effect of Lyme disease diagnosis and/or treatment on risk factor estimates derived from case-control studies. The control population drawn from the same primary care practice in an endemic area for Lyme disease allows generalizability to the primary care setting.